Phase III evaluation of 4 doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia.
Loprinzi, C L
Phase III evaluation of 4 doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia. [electronic resource] - Oncology Oct 1994 - 2-7 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
0030-2414
10.1159/000227407 doi
Administration, Oral
Adult
Aged
Aged, 80 and over
Anorexia--drug therapy
Appetite--drug effects
Cachexia--drug therapy
Female
Follow-Up Studies
Humans
Male
Megestrol--administration & dosage
Megestrol Acetate
Middle Aged
Paraneoplastic Syndromes--drug therapy
Prospective Studies
Surveys and Questionnaires
Survival Rate
Time Factors
Weight Gain
Phase III evaluation of 4 doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia. [electronic resource] - Oncology Oct 1994 - 2-7 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
0030-2414
10.1159/000227407 doi
Administration, Oral
Adult
Aged
Aged, 80 and over
Anorexia--drug therapy
Appetite--drug effects
Cachexia--drug therapy
Female
Follow-Up Studies
Humans
Male
Megestrol--administration & dosage
Megestrol Acetate
Middle Aged
Paraneoplastic Syndromes--drug therapy
Prospective Studies
Surveys and Questionnaires
Survival Rate
Time Factors
Weight Gain